Publicacións nas que colabora con Jose Manuel Cameselle Teijeiro (37)

2024

  1. dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe

    Nature Communications, Vol. 15, Núm. 1

2023

  1. Should we suspect primary aldosteronism in patients with hypokalaemic rhabdomyolysis? A systematic review

    Frontiers in Endocrinology, Vol. 14

2021

  1. The Authors Reply PMC and PMT: Real Medicine and Not Just Biology

    American Journal of Surgical Pathology

2020

  1. GFRα 1-2-3-4 co-receptors for RET Are co-expressed in Pituitary Stem Cells but Individually Retained in Some Adenopituitary Cells

    Frontiers in Endocrinology, Vol. 11

  2. Lat-1 and glut-1 carrier expression and its prognostic value in gastroenteropancreatic neuroendocrine tumors

    Cancers, Vol. 12, Núm. 10, pp. 1-18

  3. Sequential colocalization of ERa, PR, and AR hormone receptors using confocal microscopy enables new insights into normal breast and prostate tissue and cancers

    Cancers, Vol. 12, Núm. 12, pp. 1-22

  4. Thyroid papillary microtumor: Validation of the (updated) porto proposal assessing sex hormone receptor expression and mutational BRAF gene status

    American Journal of Surgical Pathology, Vol. 44, Núm. 9, pp. 1161-1172

2019

  1. Early evolutionary divergence between papillary and anaplastic thyroid cancers

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 30, Núm. 11, pp. 1843

  2. Novel TMEM127 Variant Associated to Bilateral Phaeochromocytoma with an Uncommon Clinical Presentation

    Case Reports in Endocrinology, Vol. 2019

2018

  1. Analysis of expression of the PD-1/PD-L1 immune checkpoint system and its prognostic impact in gastroenteropancreatic neuroendocrine tumors

    Scientific Reports, Vol. 8, Núm. 1

  2. Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT/β-catenin pathway

    Modern Pathology, Vol. 31, Núm. 8, pp. 1168-1179

  3. Early evolutionary divergence between papillary and anaplastic thyroid cancers

    Annals of Oncology, Vol. 29, Núm. 6, pp. 1454-1460

2017

  1. Aggressiveness of the tall cell variant of papillary thyroid carcinoma is independent of the tumor size and patient age

    Oncology Letters, Vol. 13, Núm. 5, pp. 3501-3507

  2. Comentarios sobre «Carcinoma de tiroides incidental versus no incidental: presentación clínica, tratamiento quirúrgico y pronóstico»

    Endocrinologia, Diabetes y Nutricion

  3. Rewiring of the apoptotic TGF-β-SMAD/NFκB pathway through an oncogenic function of p27 in human papillary thyroid cancer

    Oncogene, Vol. 36, Núm. 5, pp. 652-666

  4. The syndrome of central hypothyroidism and macroorchidism: IGSF1 controls TRHR and FSHB expression by differential modulation of pituitary TGFβ and Activin pathways

    Scientific Reports, Vol. 7

2015

  1. Thyroid pathology findings in Cowden syndrome: A clue for the diagnosis of the PTEN hamartoma tumor syndrome

    American Journal of Clinical Pathology, Vol. 144, Núm. 2, pp. 322-328

2013

  1. Adrenal carcinoma: A retrospective analysis of our series

    Endocrinologia y Nutricion

  2. Humanized medium (h7H) allows long-term primary follicular thyroid cultures from human normal thyroid, benign neoplasm, and cancer

    Journal of Clinical Endocrinology and Metabolism, Vol. 98, Núm. 6, pp. 2431-2441

2012

  1. Aplicación de proteómica a la búsqueda de nuevos mecanismos tumorales en cáncer de tiroides

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 8, pp. 114-114